Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets closed

S&P 500
5,973.10
+44.06(+0.74%)
Dow 30
43,729.34
-0.59(-0.00%)
Nasdaq
19,269.46
+285.99(+1.51%)
Russell 2000
2,382.69
-10.23(-0.43%)
Crude Oil
72.16
-0.20(-0.28%)
Gold
2,713.80
+8.00(+0.30%)

Pediatrix Medical Group, Inc. (MD)

NYSE - Nasdaq Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

16.04

-0.04

(-0.25%)

At close: 04:00PM EST

16.04

0.00

(0.00%)

After hours:

05:54PM EST

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	1.38B
Enterprise Value	1.84B
Trailing P/E	N/A
Forward P/E	10.38
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	0.67
Price/Book (mrq)	1.89
Enterprise Value/Revenue	0.92
Enterprise Value/EBITDA	69.27

Trading Information

Stock Price History

Beta (5Y Monthly)	1.55
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	16.41
52 Week Low ³	6.62
50-Day Moving Average ³	11.89
200-Day Moving Average ³	9.47

Share Statistics

Avg Vol (3 month) ³	653.86k
Avg Vol (10 day) ³	924.94k
Shares Outstanding ⁵	85.88M
Implied Shares Outstanding ⁶	N/A
Float ⁸	74.98M
% Held by Insiders ¹	1.72%
% Held by Institutions ¹	106.53%
Shares Short (Oct 15, 2024) ⁴	4.39M
Short Ratio (Oct 15, 2024) ⁴	7.19
Short % of Float (Oct 15, 2024) ⁴	7.20%
Short % of Shares Outstanding (Oct 15, 2024) ⁴	5.11%
Shares Short (prior month Sep 13, 2024) ⁴	4.79M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	2:1
Last Split Date ³	Dec 20, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Sep 30, 2024

Profitability

Profit Margin	-12.65%
Operating Margin (ttm)	10.26%

Management Effectiveness

Return on Assets (ttm)	4.67%
Return on Equity (ttm)	-29.86%

Income Statement

Revenue (ttm)	2.01B
Revenue Per Share (ttm)	24.17
Quarterly Revenue Growth (yoy)	0.90%
Gross Profit (ttm)	N/A
EBITDA	199.04M
Net Income Avi to Common (ttm)	-253.84M
Diluted EPS (ttm)	-2.33
Quarterly Earnings Growth (yoy)	-9.10%

Balance Sheet

Total Cash (mrq)	220.45M
Total Cash Per Share (mrq)	2.61
Total Debt (mrq)	683.65M
Total Debt/Equity (mrq)	93.33
Current Ratio (mrq)	1.42
Book Value Per Share (mrq)	8.67

Cash Flow Statement

Operating Cash Flow (ttm)	142.81M
Levered Free Cash Flow (ttm)	107.29M